Mergers & Acquisitions
Medtech investment: Deal volume drops in Q2, but analysts remain optimistic
There was good news and bad news in the latest life sciences deals report from the analysts at PricewaterhouseCoopers. Investment in the medical device industry took a hard downward turn year-over-year, but market trends signal that the life sciences market may expect a comeback before the end of 2013.
SafeStitch Medical to merge with TransEnterix, raise $30M
SafeStitch Medical (OTC:SFES) and TransEnterix are set to merge next quarter in a deal that includes a private placement worth about $30 million.
Invacare sinks and rebounds on restated Q2, sale of medical recliner business
UPDATE: Medtronic drops $200M on Cardiocom
Medtronic (NYSE:MDT) bought Cardiocom LLC for $200 million in cash in a bid to get into the disease management business.
Chanhassen, Minn.-based Cardiocom makes devices aimed at helping to manage chronic conditions like diabetes or heart disease. Fridley, Minn.-based Medtronic said the acquisition is its entree into the disease management sphere.
M&A: Theragenics and Juniper make it official
Orthofix to restate past financials on revenue snafu | Wall Street Beat
Healthcare apps: Autovative Products becomes GlassesOff, merges with Ucansi
In a complex sequence of spin-offs, name-changes and mergers, the dust has settled for vision correction company GlassesOff, formerly called Autovative Products and recently restructured through a merger with software company Ucansi.
The former Autovative Products also created a spin-off, Autovative Technologies, which will be headed by former CEO David Funderburk. Uscansi’s management and board, including CEO Nimrod Madar, will take over operations of GlassesOff.
Report: ICU Medical enters exclusive talks on private-equity buyout
ICU Medical (NSDQ:ICUI) is in exclusive talks with a Chicago-based private equity shop, GTCR LLC, about a leveraged buyout, unnamed sources told Bloomberg BusinessWeek.
Digirad sells imaging technology to Novadaq for $2 million
Digirad Corp.(NSDQ:DRAD) handed over several on-the-shelf and in-development devices to Novadaq (TSE:NDQ) in a $2 million deal that includes 5 pending patent applications and the rights to 13 existing technologies.
KCI to drop $485M on wound care company Systagenix
Kinetic Concepts Inc. said it agreed to acquire 1 of its private wound-care peers, Systagenix, for $485 million.
San Antonio, Texas-based KCI said the deal brings a large suite of complementary advanced wound care products into its portfolio.